S Oparil

2.4k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

S Oparil is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health. According to data from OpenAlex, S Oparil has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in S Oparil's work include Blood Pressure and Hypertension Studies (9 papers), Hormonal Regulation and Hypertension (4 papers) and Sodium Intake and Health (2 papers). S Oparil is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Hormonal Regulation and Hypertension (4 papers) and Sodium Intake and Health (2 papers). S Oparil collaborates with scholars based in United States, Australia and Israel. S Oparil's co-authors include D. W. Jones, Barry J. Materson, Aram V. Chobanian, George L. Bakris, Joseph L. Izzo, Jackson T. Wright, William C. Cushman, Henry R. Black, T. Rosenthal and John E. Walker and has published in prestigious journals such as Circulation, Journal of Hypertension and American Journal of Hypertension.

In The Last Decade

S Oparil

15 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

THE SEVENTH REPORT OF THE JOINT NATIONAL COMMITTEE ON PREVENTION, DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD PRESSURE. THE JNC 7 REPORT

2003 1.2k citations Aram V. Chobanian, George L. Bakris et al. Evidence-Based Eye Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S Oparil United States	7	835	324	184	163	149	15	1.4k
Carlene M. Grim United States	9	876 1.0×	323 1.0×	295 1.6×	296 1.8×	167 1.1×	15	1.6k
GT McInnes United Kingdom	14	801 1.0×	264 0.8×	234 1.3×	241 1.5×	119 0.8×	53	1.6k
K. K. Teo Canada	11	1.2k 1.5×	308 1.0×	103 0.6×	174 1.1×	89 0.6×	23	1.6k
CJ Bulpitt United Kingdom	20	1.0k 1.2×	256 0.8×	136 0.7×	222 1.4×	207 1.4×	50	1.7k
Vijaya M Musini Canada	22	710 0.9×	255 0.8×	115 0.6×	197 1.2×	192 1.3×	47	1.4k
Yu Bun Man Hong Kong	7	976 1.2×	467 1.4×	259 1.4×	292 1.8×	199 1.3×	9	1.5k
Mahendr S. Kochar United States	14	1.1k 1.3×	588 1.8×	191 1.0×	188 1.2×	231 1.6×	55	1.7k
M. Mohsen Ibrahim Egypt	18	950 1.1×	269 0.8×	250 1.4×	230 1.4×	225 1.5×	31	1.4k
Deborah M. Michel United States	4	536 0.6×	287 0.9×	254 1.4×	227 1.4×	122 0.8×	8	1.3k
Samar A. Nasser United States	19	777 0.9×	247 0.8×	211 1.1×	154 0.9×	158 1.1×	36	1.3k

Countries citing papers authored by S Oparil

Since Specialization

Citations

This map shows the geographic impact of S Oparil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Oparil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Oparil more than expected).

Fields of papers citing papers by S Oparil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Oparil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Oparil. The network helps show where S Oparil may publish in the future.

Co-authorship network of co-authors of S Oparil

This figure shows the co-authorship network connecting the top 25 collaborators of S Oparil. A scholar is included among the top collaborators of S Oparil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Oparil. S Oparil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Oparil, S, et al.. (2013). 2013 Canadian Hypertension Education Program Recommendations. 13(2). 11–11. 4 indexed citations

2.

Oparil, S, et al.. (2005). Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals. American Journal of Hypertension. 18(2). 287–294. 46 indexed citations

3.

Giles, Thomas D., et al.. (2005). Comparison of ascending doses of olmesartan medoxomil (O), losartan potassium (L) and valsartan (V) in patients (PTS) with essential hypertension (HTN). American Journal of Hypertension. 18(5). A59–A60. 3 indexed citations

4.

Chobanian, Aram V., George L. Bakris, Henry R. Black, et al.. (2003). THE SEVENTH REPORT OF THE JOINT NATIONAL COMMITTEE ON PREVENTION, DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD PRESSURE. THE JNC 7 REPORT. Evidence-Based Eye Care. 4(3). 179–180. 1159 indexed citations breakdown →

5.

Oparil, S, et al.. (2001). What do international guidelines say about therapy?. PubMed. 19(3). S23–31. 4 indexed citations

6.

Rosenthal, T. & S Oparil. (2000). Hypertension in women. Journal of Human Hypertension. 14(10-11). 691–704. 61 indexed citations

7.

Oparil, S, et al.. (2000). [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].. PubMed. 59 Spec No 2. 25–37. 5 indexed citations

8.

Kjeldsen, Sverre E., Björn Dahlöf, R.B. Devereux, et al.. (2000). CARDIOVASCULAR COMPLICATIONS IN RELATION TO THE FRAMINGHAM RISK SCORE AND AGE IN HYPERTENSIVE PATIENTS WITH LVH. Journal of Hypertension. 18. S91–S91. 4 indexed citations

9.

Oparil, S. (1999). Treating multiple-risk hypertensive populations. American Journal of Hypertension. 12(11). 121–129. 9 indexed citations

10.

Neutel, Joel M., et al.. (1999). Comparison of Telmisartan with Lisinopril in Patients with Mild-to-Moderate Hypertension. American Journal of Therapeutics. 6(3). 161–166. 68 indexed citations

11.

Oparil, S. (1998). D023 Comparison of eprosartan and enalapril on incidence of cough in hypertensive patients with history of ace inhibitor-induced cough. American Journal of Hypertension. 11(4). 74A–74A. 2 indexed citations

12.

Smith, Sidney C., S. N. Blair, Michael H. Criqui, et al.. (1996). Preventing heart attack and death in patients with coronary disease. Endorsed by the board of trustees of the American College of Cardiology.. PubMed. 32(4). 26–8. 2 indexed citations

13.

Moller, James H., Hugh D. Allen, E. B. Clark, et al.. (1993). Report of the task force on children and youth. American Heart Association.. Circulation. 88(5). 2479–2486. 42 indexed citations

14.

Oparil, S, et al.. (1989). Hypertension. Disease-a-Month. 35(3). 138–232. 3 indexed citations

15.

Karp, Robert B., et al.. (1984). A randomized comparison of crystalloid and blood-containing cardioplegic solutions in 60 patients.. Circulation. 69(5). 973–982. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact